M-m-r II vaccine vials
Ended Awarded Last action
- Contract number
- SPE2DR26F1AU5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,144
Award facts
- Contract value 100% obligated
- $8,143.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,143.76 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 29, 2026. This non-competitive, firm fixed-price delivery order was issued on January 28, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is executed under a larger Indefinite Delivery Contract (IDC) vehicle held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The parent IDC serves as a comprehensive global pharmaceutical support mechanism enabling the delivery of a broad range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support military healthcare programs worldwide. The contract supports various federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key supplier within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F1AU5?
SPE2DR26F1AU5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1AU5 worth?
The government has obligated $8,144 on SPE2DR26F1AU5.
Is contract SPE2DR26F1AU5 an order under another contract?
Yes. SPE2DR26F1AU5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AU5 competed?
The extent of competition for SPE2DR26F1AU5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award